Annual report pursuant to Section 13 and 15(d)

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS

v3.24.3
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS
 12 Months Ended
Sep. 30, 2024
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS
  Additions
Description Balance at Beginning of Period Charged to Expense Charged to other Accounts
Deductions (1)
Balance at End of Period
  (Dollar amounts in thousands)
Allowance for Doubtful Accounts:
Fiscal Year Ended:
September 30, 2024 $ 10,784  $ 2,696  $ —  $ (1,425) $ 12,055 
September 30, 2023 10,138  1,625  —  (979) 10,784 
September 30, 2022 10,654  1,368  —  (1,884) 10,138 
(1)Amounts determined not to be collectible (including direct write-offs), net of recoveries.

Description Balance at Beginning of Period
Provision Charged (Credited) To Expense (1, 3)
Allowance Changes
Other (Deductions) Additions (2,4)
Balance at End of Period
  (Dollar amounts in thousands)
Deferred Tax Asset Valuation Allowance:
Fiscal Year Ended:
September 30, 2024 $ 22,506  $ 24,152  $ —  $ (1,196) $ 45,462 
September 30, 2023 27,552  (4,709) —  (337) 22,506 
September 30, 2022 28,619  (1,300) —  233  27,552 
(1)Amounts relate primarily to adjustments in net operating loss carryforwards which are precluded from use.
(2)Fiscal 2023 and 2022 consists principally of adjustments related to foreign exchange.
(3)Fiscal 2024 amount is comprised of a $2,032 benefit related to the release of valuation allowance, and a $26,184 expense primarily related to adjustments in net operating loss carryforwards which are precluded from use. Fiscal 2022 amount is comprised of a $5,004 benefit related to non-survivability of deferred tax assets with full valuation allowance due to entity dissolution and a $3,704 expense primarily related to adjustments in net operating loss carryforwards which are precluded from use.
(4)Fiscal 2024 amount is comprised of a $2,802 decrease related to non-survivability of deferred tax assets with a full valuation allowance due to held-for-sale asset write-downs, and a $1,606 addition related to foreign exchange.